ライフサイエンスコーパス: morbidly

1 DS can be performed relatively safely in the morbidly and super morbidly obese, and does not require

2 Pre-morbidly, however, the patients with aphasia had enjoyed

3 Morbidly ill C3H mice at 14 days had severe pulmonary ed

4 pulmonary transplantation can be applied to morbidly ill patients with excellent operative and inter

5 They were more likely to be morbidly obese (32% versus 9%), have dyslipidemia (25% v

6 ersons, 1.79 (95% CI: 1.37, 2.33) for active morbidly obese (BMI > or =35) persons, and 3.45 (95% CI:

7 , categorized as severely obese (BMI 35-40), morbidly obese (BMI 40-60), and reference (BMI 18.5-35).

8 ), 113 overweight (BMI=>27-30 kg/m2), and 55 morbidly obese (BMI>30 kg/m2) patients were compared wit

9 Values were also lower for morbidly obese (BMI, > or =40.0 kg/m(2)) participants (1

10 se (BMI, 35.1-40 kg/m(2)), and 355 (2%) were morbidly obese (BMI, 40.1-50 kg/m(2)).

11 ism indices were evaluated in 15 consecutive morbidly obese (MO) subjects before and 6 and 12 months

12 With the growing number of morbidly obese adolescents in the United States coupled

13 ities, and improvement in quality of life in morbidly obese adolescents undergoing bariatric surgery

14 following surgically induced weight loss in morbidly obese adolescents.

15 lic function before and after weight loss in morbidly obese adolescents.

16 Cardiac abnormalities are present in morbidly obese adolescents; however, it is unclear if th

17 Up to a remarkable 6% of morbidly obese adults and children studied possess singl

18 hildren with severe early-onset obesity, 568 morbidly obese adults, and 383 controls.

19 (p.T46R, p.E62K, p.H323Y, and p.D740H) in 7 morbidly obese adults.

20 In the final analysis of 1,911 morbidly obese and 1,274 control subjects, rs2076349 sho

21 ardiac transplantation are increased in both morbidly obese and cachectic patients compared with norm

22 ncrease in mortality was seen at 30 days for morbidly obese and cachectic recipients (12.7% and 17.7%

23 entified in a compound heterozygote that was morbidly obese and diabetic.

24 Lepr-null control males and females were morbidly obese and exhibited delayed puberty onset, no e

25 d the peripheral blood T-cell compartment of morbidly obese and lean subjects.

26 logic effects of CO2 pneumoperitoneum in the morbidly obese and make appropriate intraoperative adjus

27 erved in hunger and satiation curves between morbidly obese and nonobese groups; however, sleeve gast

28 o a functional life, and can be performed in morbidly obese and older patients.

29 In-hospital mortality was lower in morbidly obese and overweight patients and higher in und

30 y, should be applied in all patients who are morbidly obese and present for anesthetic care.

31 Sixteen million people are morbidly obese and RYGB surgery is the most effective tr

32 Obese, morbidly obese and ultra-obese patients have multiple su

33 , obese as body mass index 30-39.9 kg/m, and morbidly obese as body mass index greater than or equal

34 Morbidly obese as well as cachectic recipients demonstra

35 ue, is associated with insulin resistance in morbidly obese bariatric surgery patients.

36 e been associated with up to 6% frequency in morbidly obese children and adults.

37 Three morbidly obese children, who were congenitally deficient

38 For morbidly obese decedents (BMI >/=40 kg/m2), the predicte

39 ith the highest rates in the underweight and morbidly obese extremes and the lowest rates in the over

40 r mortality were significantly higher in the morbidly obese group (P <.05).

41 atients stratified into nonobese, obese, and morbidly obese groups.

42 We treated these three morbidly obese homozygous leptin-deficient adult patient

43 Genetic studies of morbidly obese human patients and normal weight control

44 Morbidly obese human patients have been shown to possess

45 esity-associated insulin resistance and from morbidly obese humans and in in vitro models of adipocyt

46 evels of endogenous opioids are increased in morbidly obese humans and obese rats.

47 y higher in visceral than subcutaneous AT of morbidly obese humans.

48 Managing patients who are morbidly obese in the intensive care unit is associated

49 trates the successful use of lorcaserin in a morbidly obese individual with decompensated cirrhosis e

50 A morbidly obese individual's increased cardiac output req

51 Morbidly obese individuals are predisposed to a wide ran

52 A greater number of morbidly obese individuals are undergoing bariatric surg

53 In conclusion, a significant subset of morbidly obese individuals has portal fibrosis in the ab

54 geon decisions to operate, differences among morbidly obese individuals in access to surgery, or pati

55 sms (rs1893590 [A/C] and rs1378577 [T/G]) in morbidly obese individuals indicated that elevated ABCG1

56 rom fecal samples by using pyrosequencing in morbidly obese individuals, explored before (0 mo), 3 mo

57 Morbidly obese Medicare patients who underwent bariatric

58 ctivated K(+) (BK) channel was identified in morbidly obese men carrying a BK gene variant, supportin

59 d adipose tissue biopsies were obtained from morbidly obese nondiabetic subjects undergoing bariatric

60 s of this study when compared with a similar morbidly obese nonsurgical group (P < 0.001).

61 ed groups (studies that exclusively enrolled morbidly obese or diabetics or pediatric) and no data on

62 he OR rising to 4.03 (95% CI, 3.74-4.33) for morbidly obese participants (body mass index, >40 kg/m(2

63 Compared to the lean parturient, the morbidly obese parturient has an increased likelihood fo

64 neral anesthesia for cesarean section in the morbidly obese parturient is associated with increased m

65 to describe the anesthetic management of the morbidly obese parturient.

66 d to decrease potential complications in the morbidly obese parturient.

67 hysical and care needs of the critically ill morbidly obese patient but also navigate, both personall

68 proper attention to their special needs, the morbidly obese patient can safely undergo thoracic surge

69 GB) controls type 2 diabetes mellitus in the morbidly obese patient more effectively than any medical

70 e the management and improve outcomes of the morbidly obese patient presenting for any surgery.

71 and laryngoscopy for tracheal intubation the morbidly obese patient should be in the reverse Trendele

72 ive long-term improvement in diabetes in the morbidly obese patient with diabetes.METHODS We evaluate

73 e United States to induce weight loss in the morbidly obese patient, long-term follow-up continues to

74 A total of 2045 severely or morbidly obese patients (BMI >/= 35 kg/m, aged between 6

75 eralis) LCACoA content and insulin action in morbidly obese patients (n = 11) before and after weight

76 Three groups were studied: morbidly obese patients (n = 16), morbidly obese patient

77 obese patients (P=0.020), and 41% higher for morbidly obese patients (P=0.015).

78 ntestinal motility and hormonal responses in morbidly obese patients after sleeve gastrectomy has not

79 Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surge

80 Morbidly obese patients also benefited more from LT (88%

81 splant and sleeve gastrectomy is feasible in morbidly obese patients and adds little additional opera

82 to identify factors associated with MetS in morbidly obese patients and predictors of its remission

83 utations in the melanocortin MC4 receptor in morbidly obese patients and the finding that intranasal

84 ond one from the across-tissue comparison of morbidly obese patients and the other from the across-po

85 , trauma-related procedures and many others, morbidly obese patients are most consistently cared for

86 adverse consequences of pneumoperitoneum in morbidly obese patients are similar to those observed in

87 e, we studied brain glucose metabolism in 22 morbidly obese patients before and 6 months after bariat

88 y artery disease (TCAD) was not increased in morbidly obese patients but cachectic patients had a sig

89 We conclude that morbidly obese patients dedicate a disproportionately hi

90 Extremely or morbidly obese patients differ from patients of normal w

91 Morbidly obese patients exhibit impaired secretion of gu

92 Morbidly obese patients frequently present with mood and

93 ed' experiences of caring for critically ill morbidly obese patients from the perspectives of intensi

94 Morbidly obese patients had the highest proportion (87%)

95 Physiologically, morbidly obese patients have a higher intraabdominal pre

96 mild obesity have the best survival, whereas morbidly obese patients have the highest mortality.

97 We measured baseline VO(2) in morbidly obese patients immediately prior to gastric byp

98 al and endoscopic options for weight loss in morbidly obese patients including their efficacy and com

99 applying positive end-expiratory pressure in morbidly obese patients is not well defined.

100 Morbidly obese patients may be at increased risk of dela

101 Critically ill morbidly obese patients pose considerable healthcare del

102 size a need for specific protocols to manage morbidly obese patients presenting to the ED with chest

103 bypass has proved to be successful for many morbidly obese patients pursuing weight loss and increas

104 Sixty-six morbidly obese patients randomized to SG or RYGB were in

105 Liver biopsies and serum samples from 113 morbidly obese patients receiving bariatric surgery, hea

106 Morbidly obese patients selected for LRYGB were included

107 Consecutive morbidly obese patients selected for LSG were included i

108 Morbidly obese patients should be considered potential c

109 high-quality disease map for each tissue in morbidly obese patients to not only inform genetic assoc

110 In morbidly obese patients undergoing bariatric surgery, we

111 Morbidly obese patients undergoing laparoscopic bariatri

112 The proportion of morbidly obese patients undergoing PCI increased from 4.

113 Twenty-three morbidly obese patients underwent 1H-magnetic resonance

114 Antrum area during fasting in morbidly obese patients was statistically significant la

115 nteractions between intensive care staff and morbidly obese patients were challenging due to the soci

116 Between May 1999 and March 2001, 155 morbidly obese patients were enrolled in this prospectiv

117 effective for ureteral and renal calculi in morbidly obese patients who are not suitable candidates

118 morbid with morbid obesity were examined for morbidly obese patients who did and did not undergo bari

119 tric surgery relative to a control cohort of morbidly obese patients who did not undergo surgery.

120 e studied: morbidly obese patients (n = 16), morbidly obese patients who had had sleeve gastrectomy (

121 We performed Roux-en-Y gastric bypass in two morbidly obese patients who had undergone liver transpla

122 From January 1997 to December 2004, 50 morbidly obese patients with acute respiratory failure w

123 ssistance may influence clinical outcomes in morbidly obese patients with acute respiratory failure.

124 1994 through May 2013, one hundred and nine morbidly obese patients with biopsy-proven NASH underwen

125 cDNA from peripheral blood lymphocytes of 22 morbidly obese patients with body-mass index (BMI) betwe

126 Thirty morbidly obese patients with chronic renal failure or tr

127 r than normal weight patients (P=0.073), and morbidly obese patients with computerized tomographic sc

128 In morbidly obese patients with diabetes who were offered D

129 These data suggest that morbidly obese patients with end-stage renal disease who

130 ould be a therapeutic option for appropriate morbidly obese patients with NASH who do not respond to

131 he long-term effects of bariatric surgery in morbidly obese patients with NASH.

132 mproves symptoms and controls reflux in most morbidly obese patients with preoperative GERD.

133 formed a retrospective case-matched study of morbidly obese patients with T2DM who had undergone medi

134 insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes are still u

135 tudinal changes of glucostatic parameters in morbidly obese patients with type 2 diabetes mellitus un

136 nsulin sensitivity and beta-cell function in morbidly obese patients with type 2 diabetes mellitus wh

137 to compare long-term outcomes of 2 groups of morbidly obese patients with type 2 diabetes mellitus-1

138 Morbidly obese patients without computerized tomographic

139 an-Meier survival was significantly lower in morbidly obese patients, and morbid obesity was an indep

140 For most morbidly obese patients, in addition to causing signific

141 iversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remi

142 were 11% and 29% lower in severely obese and morbidly obese patients, respectively.

143 at Slc27a1 was increased upon weight loss in morbidly obese patients, while Sparc expression was redu

144 Ongoing alcohol drinkers and morbidly obese patients, with minimal hepatic injury and

145 30% lower in severely obese and 38% lower in morbidly obese patients.

146 icantly correlated with AST/ALT ratio in all morbidly obese patients.

147 on of postsurgical elovl6 gene expression in morbidly obese patients.

148 care setting when caring for critically ill morbidly obese patients.

149 awkward moments were evident when caring for morbidly obese patients.

150 equate for optimal mechanical ventilation of morbidly obese patients.

151 ved insulin resistance pattern compared with morbidly obese patients.

152 body weight and cardiovascular mortality in morbidly obese patients.

153 effective long-term weight loss strategy for morbidly obese patients.

154 A Roux-en-Y gastric bypass was performed in morbidly obese patients.

155 hat covers the entire spectrum of lesions in morbidly obese patients.

156 he standard operation for T2DM resolution in morbidly obese patients.

157 elopment of new health-related conditions in morbidly obese patients.

158 roposed clinical scoring can predict NASH in morbidly obese persons with sufficient accuracy to be co

159 system to predict the probability of NASH in morbidly obese persons, thus assisting in the decision t

160 , and 3.45 (95% CI: 2.79, 4.00) for inactive morbidly obese persons.

161 lcoholic steatohepatitis (NASH) is common in morbidly obese persons.

162 Morbidly obese recipients experienced a shorter time to

163 4.8% of the nuclear families possessed >or=1 morbidly obese sibling (BMI >or=40).

164 Sixty-one morbidly obese subjects (41.7 +/- 0.6 kg/m) with type 2

165 ignificantly higher both in the severely and morbidly obese subjects (P <.05), mostly as a result of

166 We analyzed liver biopsies from 195 morbidly obese subjects after excluding all other causes

167 We exome-sequenced 200 morbidly obese subjects and 100 control subjects with po

168 were endoscopically collected from lean, and morbidly obese subjects before and 3 months after laparo

169 )/F) was elevated approximately threefold in morbidly obese subjects compared with controls (P <.001)

170 Morbidly obese subjects had a selective increase in peri

171 Morbidly obese subjects had significantly lower MOR avai

172 The peripheral blood T-cell compartment of morbidly obese subjects is characterized by increased ho

173 and left lobe--in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery emp

174 e physiologic effects of pneumoperitoneum in morbidly obese subjects undergoing laparoscopy.

175 Morbidly obese subjects were enrolled in a single arm, o

176 Cross-sectional study in 18 T2DM morbidly obese subjects who underwent RYGBP but differed

177 2-hour mixed-meal tolerance (MMT) test in 20 morbidly obese subjects with type 2 diabetes who underwe

178 We studied 16 morbidly obese subjects with varying degrees of hepatic

179 Fourteen morbidly obese subjects, 7 with normal glucose tolerance

180 , hepatic CYP2E1 activity is up-regulated in morbidly obese subjects.

181 ICU mortality was lower in morbidly obese than in normal body mass index patients (

182 Waitlist mortality was higher for morbidly obese than normal/overweight patients (subdistr

183 In Latinas, only the morbidly obese were at high risk of death (HR = 2.26, 95

184 The risk in morbidly obese women (BMI > or = 40) was higher (OR: 1.3

185 We studied 13 morbidly obese women [mean body mass index (BMI), 42 kg/

186 Of the 30 morbidly obese women who participated in the study, 21 h

187 as a beneficial effect on symptoms of PFD in morbidly obese women.

188 l history is notable for overweight (but not morbidly obese), hypercholesterolemia, hypertension, cat

189 obese, 1.11 for severely obese, and 1.22 for morbidly obese).

190 relatively safely in the morbidly and super morbidly obese, and does not require a 2-stage procedure

191 o 39.9 kg/m, severely obese; and >/=40 kg/m, morbidly obese, and evaluated waitlist outcomes using co

192 in each of the categories of normal weight, morbidly obese, and post-gastric-bypass surgery.

193 All 3 patients were morbidly obese, and workup revealed underlying cancer in

194 In the morbidly obese, at high minute ventilations, VO(2RESP) i

195 obese, 0.72 for severely obese, and 0.56 for morbidly obese, compared with a reference group of patie

196 Homozygous Cep19-knockout mice were morbidly obese, hyperphagic, glucose intolerant, and ins

197 METHODS AND The db/db mouse is morbidly obese, insulin-resistant, and has tissue-specif

198 Another study showed that, in the morbidly obese, nasal ventilation might be advantageous

199 dies compare surgical patients to a similar, morbidly obese, nonsurgical cohort, especially in high-r

200 reased intra-abdominal pressure, such as the morbidly obese, suffer from a high frequency rate of idi

201 eight, normal weight, overweight, obese, and morbidly obese, were compared using the Kruskall-Wallis

202 As a result, the transgenic mice were morbidly obese, with significantly higher levels of adip

203 monly experienced with the those who are not morbidly obese.

204 ortance to the critically ill patient who is morbidly obese.

205 ysiologic effects of pneumoperitoneum in the morbidly obese.

206 About 5% of the US population is morbidly obese.

207 nd 3.5% of 38 177 transplanted patients were morbidly obese.

208 tial health benefits for many people who are morbidly obese.

209 patients (66.4%) were overweight, obese, or morbidly obese.

210 merica (overweight: 37.1%, obese: 36.5%, and morbidly obese: 5.8%; P<.001 vs other regions).

211 or demographics and comorbidities, being pre-morbidly overweight (hazard ratio [HR]: 0.72; 95% confid